FDA DEVICE FACTS
EndoTool SubQ 2.1
Monarch Medical Technologies, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Calculate recommended doses of insulin for subcutaneous delivery and carbohydrate doses, to adjust and maintain the blood glucose level within a configurable clinician-determined target range. Same User group / patient range 12 kg and 2yr or greater Same Dose calculation Creates patient-specific insulin and carbohydrate dose recommendations; evaluates current glucose value and glucose trends; based on user inputs. Same Environment of use All patient care settings Same Operating system and browser compatibility Microsoft Windows; Internet Explorer, Microsoft Edge, Google Chrome, Mozilla Firefox.
Same Device & Predicate Device(s): K211160 K180366 General Device Characteristic Differences Insulin dosing protocols Basal/bolus/correction, basal/correction, bolus/correction, or correction only Basal/bolus/correction, bolus/correction, or correction only User Interface EndoTool SubQ 2.1 user interface
• Nutrition and Events information moved to new page
• New “explain the dose” feature assists users in understanding how a recommended dose was calculated.
• Integration with facility’s computer physician order entry (CPOE) and medication administration record (MAR) EndoTool Sub Q user interface Warnings Yes – New warnings / controls regarding potassium added. Yes
V Standards/Guidance Documents Referenced:
ANSI AAMI IEC 62304:2006/A1:2016 Medical device software - Software life cycle processes
ANSI AAMI ISO 14971:2007 Medical Devices - Applications of Risk Management To Medical Devices
VI Performance Characteristics:
Software Documentation The level of concern for this software is major. Software documentation consistent with a major level of concern was provided as described in the FDA guidance for the Content of Premarket Submissions for Software Contained in Medical Devices. Documentation included complete software requirements and design specification documentation, detailed depiction of functional units and software modules, state diagrams and flowcharts, software lifecycle development plan with annotated listing of control documents generated during development process, configuration management plan, and verification and validation at unit, integration, and system levels with protocols, pass/fail criteria, and results.
Software verification and validation testing was conducted per IEC 62304 and included the following:
• Requirements-based unit, integration, and system-level tests
• Endo-Tool regression testing including: o Requirements-based testing for risk-related requirements o Automated algorithm test cases for the complete application o Static analysis of the software code
VII Proposed Labeling:
The labeling supports the finding of substantial equivalence for this device.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。